1. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation;Aguilera;Regul. Pept.,2000
2. Recent advances in the discovery and development of vasopressin antagonists: Peptide and nonpeptide V-1a and V-2 receptor antagonists;Albright;Curr. Pharm. Des.,1997
3. Species heterogeneity and antidiuretic hormone antagonists: what are the predictors?;Allison,1988
4. Molecular pharmacology of AVP and OT receptors and therapeutic potential;Barberis;Drug News Perspect.,1999
5. OPC-21268, an orally effective, nonpeptide arginine vasopressin V1 receptor antagonist reduces vasogenic brain edema;Bemana;Acta Neurochir. Suppl. (Wien),1997